Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
about
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis.
P2860
Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
@en
type
label
Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
@en
prefLabel
Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
@en
P2093
P2860
P50
P356
P1476
Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
@en
P2093
Martin G Larson
Ramachandran S Vasan
P2860
P356
10.1161/JAHA.115.002347
P577
2015-12-31T00:00:00Z